OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Management Strategies for Antidepressant-Related Sexual Dysfunction: A Clinical Approach
Ángel L. Montejo, N. Prieto, Rubén de Alarcón, et al.
Journal of Clinical Medicine (2019) Vol. 8, Iss. 10, pp. 1640-1640
Open Access | Times Cited: 83

Showing 1-25 of 83 citing articles:

Erectile dysfunction and diabetes: A melting pot of circumstances and treatments
Giuseppe Defeudis, Rossella Mazzilli, Marta Tenuta, et al.
Diabetes/Metabolism Research and Reviews (2021) Vol. 38, Iss. 2
Open Access | Times Cited: 162

Depression and Anxiety Disorders
Oğuz Karamustafalıoğlu, Hüseyin Yumrukçal
(2025), pp. 335-476
Closed Access | Times Cited: 7

Erectile and Ejaculatory Dysfunction Associated with Use of Psychotropic Drugs: A Systematic Review
Margherita Trinchieri, Martina Trinchieri, Gianpaolo Perletti, et al.
The Journal of Sexual Medicine (2021) Vol. 18, Iss. 8, pp. 1354-1363
Closed Access | Times Cited: 43

Vortioxetine in major depressive disorder: from mechanisms of action to clinical studies. An updated review
Javier de Diego-Adeliño, José Manuel Crespo, Fernando A. Lázaro Mora, et al.
Expert Opinion on Drug Safety (2021) Vol. 21, Iss. 5, pp. 673-690
Open Access | Times Cited: 41

ERK1/2-dependent BDNF synthesis and signaling is required for the antidepressant effect of microglia stimulation
Xu Lu, Huijun Liu, Zixuan Cai, et al.
Brain Behavior and Immunity (2022) Vol. 106, pp. 147-160
Closed Access | Times Cited: 29

Tolerance-inducing effect and properties of innate immune stimulation on chronic stress-induced behavioral abnormalities in mice
Yue Gu, Ting Ye, Pingping Tan, et al.
Brain Behavior and Immunity (2020) Vol. 91, pp. 451-471
Closed Access | Times Cited: 44

Switching to Vortioxetine in Patients with Poorly Tolerated Antidepressant-Related Sexual Dysfunction in Clinical Practice: A 3-Month Prospective Real-Life Study
Ángel L. Montejo, Froilán Sánchez-Sánchez, Rubén de Alarcón, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 2, pp. 546-546
Open Access | Times Cited: 5

The Importance of a Multi-Disciplinary Approach to the Endometriotic Patients: The Relationship between Endometriosis and Psychic Vulnerability
Manuel Glauco Carbone, Giovanni Campo, Enrico Papaleo, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 8, pp. 1616-1616
Open Access | Times Cited: 29

Management Strategies for Antipsychotic-Related Sexual Dysfunction: A Clinical Approach
Ángel L. Montejo, Rubén de Alarcón, N. Prieto, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 2, pp. 308-308
Open Access | Times Cited: 27

Wechselspiel zwischen Depression und Sexualität
Jörg Signerski-Krieger, Lara Schleifenbaum
Der Nervenarzt (2025)
Closed Access

Bifidobacterium breve BB05 alleviates depressive symptoms in mice via the AKT/mTOR pathway
Yuqin Pan, Qianhua Huang, Yuan Liang, et al.
Frontiers in Nutrition (2025) Vol. 12
Open Access

Challenges in Managing Depression in Clinical Practice: Result of a Global Survey
Nilamadhab Kar
Pharmacoepidemiology (2025) Vol. 4, Iss. 1, pp. 5-5
Open Access

A novel synthetic approach for the Piperazynyl Pyrimidine Intermediate: Focus on the cost cutting of Buspirone drug at commercial level
A. NAYAK, Divya Bajpai Tripathy, Dhananjay S. Pendharkar, et al.
Drug Development and Industrial Pharmacy (2025), pp. 1-23
Closed Access

Drug-Induced Sexual Dysfunction: An Analysis of Reports to a National Pharmacovigilance Database
Carolina Valeiro, Cristiano Matos, Joep Scholl, et al.
Drug Safety (2022) Vol. 45, Iss. 6, pp. 639-650
Closed Access | Times Cited: 16

Relationship between dietary niacin intake and erectile dysfunction: a population-based study
Weilong Lin, Cheng Zheng, Hao-Xu Wang, et al.
Asian Journal of Andrology (2024) Vol. 26, Iss. 4, pp. 382-388
Open Access | Times Cited: 3

Sexual Dysfunction Induced by Antidepressants—A Pharmacovigilance Study Using Data from VigiBaseTM
René Zeiss, Kathrin Malejko, Bernhard J. Connemann, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 7, pp. 826-826
Open Access | Times Cited: 3

Sexuality and Mental Health: The Need for Mutual Development and Research
Ángel L. Montejo
Journal of Clinical Medicine (2019) Vol. 8, Iss. 11, pp. 1794-1794
Open Access | Times Cited: 27

Sex differences in pharmacological treatment of major depressive disorder: results from the AMSP pharmacovigilance program from 2001 to 2017
Johanna Seifert, Fabienne Führmann, Matthias A. Reinhard, et al.
Journal of Neural Transmission (2021) Vol. 128, Iss. 6, pp. 827-843
Open Access | Times Cited: 23

Post-SSRI Sexual Dysfunction (PSSD): Biological Plausibility, Symptoms, Diagnosis, and Presumed Risk Factors
Liran C. Peleg, David Rabinovitch, Yaakov Lavie, et al.
Sexual Medicine Reviews (2021) Vol. 10, Iss. 1, pp. 91-98
Closed Access | Times Cited: 23

Comparative effectiveness of repeated ketamine infusions in treating anhedonia in bipolar and unipolar depression
Wei Zheng, Li-Mei Gu, Chen-Hui Sun, et al.
Journal of Affective Disorders (2021) Vol. 300, pp. 109-113
Closed Access | Times Cited: 23

The association of depressive symptoms and female sexual functioning in the menopause transition: a cross-sectional study
Emily B. Stevens, Wendy Wolfman, Leticia Hernández-Galán, et al.
Menopause The Journal of The North American Menopause Society (2024) Vol. 31, Iss. 3, pp. 186-193
Closed Access | Times Cited: 2

Design, synthesis, and biological evaluation of aralkyl piperazine and piperidine derivatives targeting SSRI/5-HT1A/5-HT7
Jianwei Wu, Zixue Zhang, Qingwei Zhang, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 104, pp. 117698-117698
Closed Access | Times Cited: 2

Off-label higher doses of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder: Safety and tolerability
Daniel Minkin Levy, Oded Ben Arush, Lior Carmi, et al.
Comprehensive Psychiatry (2024) Vol. 133, pp. 152486-152486
Open Access | Times Cited: 2

Page 1 - Next Page

Scroll to top